Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Targeting endolysosomes may help treat COVID-19.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Skin rashes can help diagnose COVID-19 early.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

New treatments using advanced technology aim to improve dry eye disease care.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Nanotechnology could improve scar treatment but needs more development.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Integrating biological networks improves drug repurposing and ADR prediction.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Extracellular vesicles can help regenerate bones but need more research for safe clinical use.